DK Life Science Co., Ltd. (KOSDAQ:303810)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,920.00
-380.00 (-4.09%)
Jun 27, 2025, 3:30 PM KST
-30.85%
Market Cap 146.65B
Revenue 133.30B
Net Income 3.80B
Shares Out 15.99M
EPS 277.14
PE Ratio 38.57
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 138,808
Average Volume 95,282
Open 9,300.00
Previous Close 9,300.00
Day's Range 8,900.00 - 9,300.00
52-Week Range 8,770.00 - 16,750.00
Beta n/a
RSI 40.13
Earnings Date n/a

About DK Life Science

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally. It offers active pharmaceutical ingredients (API), injection, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instrument. The company was founded in 2017 and is based in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 2017
Employees 100
Stock Exchange KOSDAQ
Ticker Symbol 303810
Full Company Profile

News

There is no news available yet.